Financial PerformanceQuipt reported strong growth with FQ124 revenues at $65.4M, exceeding expectations and representing a 60% increase year-over-year.
New Product OfferingThe company announced it will start offering diabetes products, such as continuous glucose monitors, to drive long-term growth.
Share Repurchase ProgramA share repurchase program of up to 10% of the public float was announced, which is seen as a smart use of capital given the stock's current valuation.